UBS Adjusts HCA Healthcare Price Target to $207 From $241, Maintains Buy Rating
© MT Newswires 2022
All news about HCA HEALTHCARE, INC. |
|
|
|
Analyst Recommendations on HCA HEALTHCARE, INC. |
|
|
| |
|
Sales 2022 |
60 407 M
-
-
|
Net income 2022 |
5 061 M
-
-
|
Net Debt 2022 |
38 271 M
-
-
|
P/E ratio 2022 |
12,7x |
Yield 2022 |
1,02% |
|
Capitalization |
61 722 M
61 722 M
-
|
EV / Sales 2022 |
1,66x |
EV / Sales 2023 |
1,57x |
Nbr of Employees |
244 000 |
Free-Float |
74,9% |
|
Chart HCA HEALTHCARE, INC. |
|
Duration :
Period :
|
 |
|
Technical analysis trends HCA HEALTHCARE, INC.
| Short Term | Mid-Term | Long Term | Trends | Bullish | Neutral | Neutral |
Income Statement Evolution
|
Mean consensus |
BUY |
Number of Analysts |
24 |
Last Close Price |
215,04 $ |
Average target price |
235,91 $ |
Spread / Average Target |
9,71% |
|